68Ga-ABS011

ABS011 · Abscint NV/SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-ABS011, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 [Phase 2]